Table 2.

BIAS outcome details, pathological features and Xpert test results by active surveillance outcome.

		Total	Failure	Not Failure	Other	p-value
		N = 139	N = 68	N = 65	N = 6
BIAS history, N (%)	Already enrolled	61 (100)	30 (49.2)	27 (44.3)	4 (6.56)	0.494
	Newly enrolled	78 (100)	38 (48.7)	38 (48.7)	2 (2.60)
AS outcome details, N (%)	No more lesion	6 (100)	n.r.	6 (100)	n.r.	<0.001
	On AS	55 (100)	n.r.	55 (100)	n.r.
	Death for other cause	6 (100)	n.r.	4 (66.6)	2 (33.3)
	Lost at follow-up	4 (100)	n.r.	n.r.	4 (100)
	Increase in size	32 (100)	32 (100)	n.r.	n.r.
	Increased number	14 (100)	14 (100)	n.r.	n.r.
	Hematuria	6 (100)	6 (100)	n.r.	n.r.
	UC: positive\suspected	5 (100)	5 (100)	n.r.	n.r.
	Increased N° and size	3 (100)	3 (100)	n.r.	n.r.
	Increased size and Hematuria	5 (100)	5 (100)	n.r.	n.r.
	UC and Increase N°	1 (100)	1 (100)	n.r.	n.r.
	Increased size, hematuria & UC	1 (100)	1 (100)	n.r.	n.r.
	Voluntary withdrew	1 (100)	1 (100)	n.r.	n.r.
TURBT stage, N (%)	Negative	9 (100)	9 (100)		0 (0.00)	0.89
	pTa	52 (100)	51 (98.0)		1 (2.00)
	pT1	3 (100)	3 (100)		0 (0.00)
TURBT grade, N (%)	Low grade	46 (100)	45 (97.8)		1 (2.20)	0.66
	High grade	9 (100)	9 (100)		0 (0.00)
Xpert Xpert 1st point, N (%)	Negative	57 (100)	20 (35.1)	36 (63.2)	1 (1.70)	0.005
	Positive	82 (100)	48 (58.5)	29 (35.4)	5 (6.10)
Xpert Xpert 2nd point, N (%)	Negative	34 (100)	9 (26.5)	25 (73.5)		0.13
	Positive	12 (100)	6 (50.0)	6 (50.0)
Xpert Xpert 3rd point, N (%)	Negative	25 (100)	4 (16.0)	21 (84.0)		0.39
	Positive	4 (100)	0 (0.00)	4 (100)
Xpert Xpert 4th point, N (%)	Negative	25 (100)	3 (12.0)	22 (88.0)

AS, active surveillance; BIAS, Bladder Cancer Italian Active Surveillance; n.r., not reported; TUBRT, transurethral resection of bladder tumor; UC, urinary cytology.